Navigation Links
Inverness Medical Innovations to Present at Canaccord Adams 28th Annual Growth Conference on August 12, 2008
Date:8/6/2008

WALTHAM, Mass., Aug. 6 /PRNewswire-FirstCall/ -- Inverness Medical Innovations, Inc. (Amex: IMA) today announced that it will attend the Canaccord Adams 28th Annual Growth Conference on Tuesday, August 12, 2008 at the InterContinental Boston in Boston, Massachusetts. Jon Russell, Vice President Finance, is scheduled to present at 4:30 pm and his presentation will be made available to the public through a webcast accessible at http://www.corporateir.net/ireye/conflobby.zhtml?ticker=IMA&item_id=1887690 , as well as via Inverness' website at http://www.invmed.com/investors.cfm. The webcast replay will be available approximately 1 hour after the presentation ends and will remain accessible for 90 days. During its presentation, Inverness may discuss and answer questions concerning business and financial developments and trends. Responses to questions, as well as other matters discussed during the webcast, may contain or constitute information that has not been disclosed previously.

By developing new capabilities in near-patient diagnosis, monitoring and health management, Inverness Medical Innovations enables individuals to take charge of improving their health and quality of life. A global leader in rapid point-of-care diagnostics, Inverness' products, as well as its new product development efforts, focus on infectious disease, cardiology, oncology, drugs of abuse and women's health. Inverness is headquartered in Waltham, Massachusetts.

For more information about Inverness Medical Innovations, please visit our website at http://www.invernessmedical.com.


'/>"/>
SOURCE Inverness Medical Innovations, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Inverness Medical Innovations Announces Second Quarter 2008 Results
2. Inverness Medical Innovations to Present at Jefferies 2nd Annual Healthcare Conference held on June 25, 2008
3. Inverness Medical Innovations to Present at 7th Annual Needham & Company, LLC Biotechnology & Medical Technology Conference on June 12, 2008
4. Inverness Medical Innovations to Present at FBR Capital Markets 12th Annual Spring Investor Conference on May 28, 2008
5. Inverness Medical Innovations Completes Acquisition of Matria Healthcare, Inc.
6. Inverness Medical Innovations to Participate at Morgan Stanley Global Healthcare Unplugged Conference on April 30, 2008
7. Inverness Medical Innovations Announces First Quarter 2008 Results
8. Inverness Medical Innovations to Close Cholestech, HemoSense and BioStar Facilities
9. Inverness Medical Innovations to Participate at Bank of America 2008 Smid Cap Conference on March 26, 2008
10. Inverness Medical Innovations Announces Fourth Quarter 2007 Results
11. Inverness Medical Innovations Completes Acquisition of BBI Holdings Plc
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/16/2017)... LOUISVILLE, Ky. , Jan. 16, 2017  Eurofins ... service, which will allow more customers to receive their ... price premium or compromise in quality found with other ... the United States at no additional ... variety of routine genetic studies, including DNA sequencing, genotyping, ...
(Date:1/13/2017)... ... 13, 2017 , ... Two Kalamazoo entrepreneurs have launched AgTonik ... that farms, greenhouses and hydroponics operations use to increase yields and promote plant ... segments of customers using this high grade fulvic acid extracted from a mineral ...
(Date:1/12/2017)... Ca (PRWEB) , ... January ... ... low-cost, disposable devices with short response times capable of performing routine electrochemical ... fields, disposable screen-printed electrodes provide fast, sensitive detection and quantification of various ...
(Date:1/12/2017)... January 12, 2017 A new report published by Allied Market ... Global Opportunity Analysis and Industry Forecast, 2014-2022," projects that the global in vitro toxicity ... at a CAGR of 15.07% during the forecast period. ... ... ...
Breaking Biology Technology:
(Date:1/4/2017)... Jan. 4, 2017  CES 2017 – Valencell ... technology, today announced the launch of two new ... the highly-accurate biometric sensor modules that incorporate the ... experience and expertise. The two new designs include ... for hearables, and Benchmark BW2.0, a 2-LED version ...
(Date:12/22/2016)... -- SuperCom (NASDAQ:   SPCB ... Public Safety, HealthCare, and Finance sectors announced today that Leaders in ... implement and deploy a community-based supportive services program to reduce recidivism ... further expanding its presence in the state. ... This new program, which is expected to ...
(Date:12/19/2016)... España y TORONTO , 19 de diciembre de ... Biologics Inc. que permitirá el desarrollo acelerado de MSC-1, un anticuerpo ... varios tipos de tumor en 2017, con múltiples sitios previstos a ... ... con objetivo en el factor inhibidor de leucemia (LIF), una citoquina ...
Breaking Biology News(10 mins):